4//SEC Filing
LOGAN CAROLYN J 4
Accession 0001209191-12-037339
CIK 0001009356other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:30 PM ET
Size
10.4 KB
Accession
0001209191-12-037339
Insider Transaction Report
Form 4
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2012-07-02$54.44/sh−17,357$944,915→ 627,131 total
Holdings
- 400,000(indirect: by GRAT)
Common Stock
- 44,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying) - 33,750
Option to Buy Common Stock
Exercise: $7.60Exp: 2013-07-24→ Common Stock (33,750 underlying) - 33,750
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (33,750 underlying) - 65,625
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (65,625 underlying)
Footnotes (2)
- [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
- [F2]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeother
Related Parties
1- filerCIK 0001212670
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:30 PM ET
- Size
- 10.4 KB